Melissa Knox, OTR/L | |
589 Highland Ave, Needham, MA 02494-2205 | |
(781) 455-9090 | |
Not Available |
Full Name | Melissa Knox |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 589 Highland Ave, Needham, Massachusetts |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1417420258 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 12629 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Melissa Knox, OTR/L 5 Constitution Ct Apt 324, Hopkinton, MA 01748-2925 Ph: () - | Melissa Knox, OTR/L 589 Highland Ave, Needham, MA 02494-2205 Ph: (781) 455-9090 |
News Archive
Cerenis Therapeutics SA (Cerenis), a biopharmaceutical company specializing in the research and development of novel therapies based on the metabolism of HDL (the "good" cholesterol) to treat cardiovascular and other metabolic diseases, announced today it has raised €40 million in the first close of its series C financing. In this round €20 million came from the Fund for Strategic Investment (FSI) with an additional €20 million coming from the existing investors: Sofinnova Partners, HealthCap, Alta Partners and TVM Capital, EDF Ventures, OrbiMed and DAIWA Corporate Investment.
Glioblastoma is a serious and incurable brain cancer. Patients receiving this diagnosis typically have 11-20 months to live. One of the main difficulties in treating this cancer is that its cells quickly build up a resistance to chemotherapy.
Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has purchased the ANDA for clindamycin phosphate (1%) and benzoyl peroxide (5%) gel from KV Pharmaceutical for $14 million in cash at closing and a $2 million milestone payment upon the completion of a successful technical transfer. This product is the AB-rated equivalent to Stiefel Laboratories' (a subsidiary of Glaxo SmithKline) Duac(R) gel, indicated for the topical treatment of inflammatory acne vulgaris.
HIV is so deadly largely because it evolves so rapidly. With a single virus as the origin of an infection, most patients will quickly come to harbor thousands of different versions of HIV, all a little bit different and all competing with one another to most efficiently infect that person's cells. Its rapid and unique evolution in every patient is what allows HIV to evade the body's defenses and gives the virus great skill at developing resistance to a pantheon of antiviral drugs.
› Verified 9 days ago
Mrs. Erin Sergi, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 255 Highland Ave, Needham, MA 02494 Phone: 781-449-1884 | |
Daryan Lemire, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 255 Highland Ave, Needham, MA 02494 Phone: 781-449-7972 | |
Ms. Sharon Paula Serinsky, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 16 Cefalo Rd, Needham, MA 02494 Phone: 781-444-1372 | |
Kara Daher, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 865 Central Ave, Needham, MA 02492 Phone: 877-736-4371 | |
Jane Crimmins, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 255 Highland Ave, Needham, MA 02494 Phone: 877-869-3016 | |
Kathleen Gardner, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 589 Highland Ave, Needham, MA 02494 Phone: 781-455-9090 | |
All4mychild Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7 Cranberry Ln, Needham, MA 02492 Phone: 508-596-3416 |